FIELD: medicine.
SUBSTANCE: invention refers to dentistry and discloses a method for determining the effectiveness of treating an individual diagnosed with inflammation in the oral cavity. Method involves obtaining a test sample of material from the oral cavity, such as saliva, from said subject, determining the amount of polymorphonuclear neutrophils or indicator substance polymorphonuclear neutrophils in said analysed sample, comparing the number of polymorphonuclear neutrophils or the indicator substance of polymorphonuclear neutrophils in said analysed sample with control and selecting a treatment regimen.
EFFECT: method enables to monitor progression of treating inflammation of the oral cavity.
17 cl, 30 tbl
Title | Year | Author | Number |
---|---|---|---|
COMPLEX FOR PREVENTION OF ORAL CAVITY OXIDATIVE STRESS | 2019 |
|
RU2748338C2 |
METHOD FOR ASSESSING THE DEGREE OF ORAL HALITOSIS | 2020 |
|
RU2755170C1 |
METHODS AND SETS FOR ORAL CAVITY CARE | 2007 |
|
RU2493816C2 |
COMPOSITIONS AND METHODS FOR PREVENTION OR REDUCTION OF DENTAL DEPOSIT AND/OR GINGIVITIS | 2004 |
|
RU2378023C2 |
METHOD OF COMPLEX TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES OF PERIODONTAL AND ORAL MUCOSA IN PERSONS WITH IODINE DEFICIENCY | 2023 |
|
RU2813153C1 |
TOOTH PASTE CONTAINING COMPLEX OF HYDROLASES | 2013 |
|
RU2527692C1 |
METHOD FOR PREVENTION OF GINGIVITIS AND HYPOSALIVATION IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS | 2017 |
|
RU2685787C1 |
NONABRASIVE TOOTH PASTE CONTAINING PAPAIN, DEXTRANASE, ALPHA-AMILASE, POTASSIUM OR AMMONIUM THIOCYANATE, INVERTASE OR GLUCOAMYLASE, GLUCOSE OXIDASE, LACTOPEROXIDASE, LYSOZYME OR LACTOFERRIN AND LACTULOSE ENZYMES | 2009 |
|
RU2407512C1 |
TOOTH PASTE CONTAINING BUFFER MIXTURE | 2013 |
|
RU2527691C1 |
MYRTLE ORAL CARE COMPOSITION | 2007 |
|
RU2469703C2 |
Authors
Dates
2019-10-10—Published
2014-06-05—Filed